Cytomegalovirus (CMV) CD8 t-cell immune competence, quantitative assessment by Flow Cytometry

Alphabetical Test listing

Cytomegalovirus (CMV) CD8 t-cell immune competence, quantitative assessment by Flow Cytometry-994

  
Cytomegalovirus (CMV) CD8 t-cell immune competence, quantitative assessment by Flow Cytometry
  
994
  
LAB994
  
MSO
  
CMV (Cytomegalovirus)
Cytomegalic inclusion disease (CMID)
Cytomegalovirus (CMV)
CMID (Cytomegalic Inclusion Disease)
  
  • Assessing cytomegalovirus (CMV)-specific immune competence in allo-hematopoietic stem cell transplantation patients who are at risk for developing late CMV disease (beyond day 100 after transplant)
  • Assessing CMV-specific immune competence in solid organ transplant patients who are at high risk for CMV reactivation post-transplant
  • Monitoring immune competence in patients post-primary CMV infection after transplant who are at risk for CMV reactivation after the cessation of antiviral prophylaxis
  • Identifying individuals who are likely to be protected from post-transplant CMV infection and those who are at higher risk of CMV reactivation
  • The global CD8 T cell immune competence assay is useful for determining over immunosuppression within the CD8 T cell compartment, when used on transplant recipients and patients with autoimmune disorders receiving therapy with immunosuppressant agents
  
Sodium heparin (Na hep) whole blood
  
  
20 mL
  
10 mL
  

Do not spin; submit specimen in original collection tube

  

Dk green Sodium heparin (Na hep), no gel

  

Ambient - 48 hours

Specimens are required to be received in the laboratory weekdays and by 4 p.m. on Friday. It is recommended that specimens arrive within 24 hours of draw.

  
Mayo Clinic Laboratories (CMVC8): R-NX
  
Mo - Fr
  
3 - 6 days
  

Flow Cytometry

  

See report

  
86356 x6
86359
86352
  
Yes
  
  
06/13/2019
  
06/13/2019